|
43
|
203
|
3iawA |
Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [gly51;aib51']hiv-1 protease molecule complexed with mvt-101 reduced isostere inhibitor at 1.6 a resolution |
|
16
|
99
|
3i7eA |
Co-crystal structure of hiv-1 protease bound to a mutant resistant inhibitor uic-98038 |
|
100
|
388
|
3igbA |
Bace-1 with compound 3 |
|
17
|
99
|
3i8wA |
Crystal structure of a metallacarborane inhibitor bound to hiv protease |
|
15
|
99
|
3ia9A |
Crystal structure of a chemically synthesized [d25n]hiv-1 protease molecule complexed with mvt-101 reduced isostere inhibitor |
|
11
|
99
|
3hvpA |
Conserved folding in retroviral proteases. crystal structure of a synthetic hiv-1 protease |
|
91
|
390
|
3hvgA |
Structure of bace (beta secretase) in complex with ev0 |
|
16
|
99
|
3i2lA |
Crystal structure of a chemically synthesized [allo-ile50/50']hiv-1 protease molecule complexed with mvt-101 reduced isostere inhibitor |
|
19
|
99
|
3i6oA |
Crystal structure of wild type hiv-1 protease with macrocyclic inhibitor grl-0216a |
|
91
|
388
|
3i25A |
Potent beta-secretase 1 hydroxyethylene inhibitor |
|
97
|
389
|
3hw1A |
Structure of bace (beta secretase) in complex with ligand ev2 |
|
42
|
203
|
3hzcA |
Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [gly51;aib51']hiv-1 protease molecule complexed with mvt-101 reduced isostere inhibitor |
|
18
|
99
|
3h5bA |
Crystal structure of wild type hiv-1 protease with novel p1'-ligand grl-02031 |
|
17
|
99
|
3hboA |
Crystal structure of chemically synthesized [d-ala51/51']hiv-1 protease |
|
18
|
99
|
3hdkA |
Crystal structure of chemically synthesized [aib51/51']hiv-1 protease |
|
43
|
203
|
3hloA |
Crystal structure of chemically synthesized 'covalent dimer' [gly51/d-ala51']hiv-1 protease |
|
15
|
99
|
3hauA |
Crystal structure of chemically synthesized hiv-1 protease with reduced isostere mvt-101 inhibitor |
|
83
|
386
|
3hd8A |
Crystal structure of the triticum aestivum xylanase inhibitor-iia in complex with bacillus subtilis xylanase |
|
18
|
99
|
3hawA |
Crystal structure of [l-ala51/51']hiv-1 protease with reduced isostere mvt-101 inhibitor |
|
18
|
99
|
3ggaA |
Hiv protease inhibitors with pseudo-symmetric cores |
|
97
|
388
|
3h0bA |
Discovery of aminoheterocycles as a novel beta-secretase inhibitor class |
|
14
|
99
|
3ggvA |
Hiv protease, pseudo-symmetric inhibitors |
|
18
|
99
|
3gi4A |
Crystal structure of protease inhibitor, kb60 in complex with wild type hiv-1 protease |
|
18
|
99
|
3gi6A |
Crystal structure of protease inhibitor, ad78 in complex with wild type hiv-1 protease |
|
18
|
99
|
3gi5A |
Crystal structure of protease inhibitor, kb62 in complex with wild type hiv-1 protease |
|
15
|
99
|
3ggxA |
Hiv protease, pseudo-symmetric inhibitors |
|
41
|
203
|
3gi0A |
Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [l-ala51,d-ala51'] hiv-1 protease molecule complexed with jg-365 inhibitor |
|
19
|
99
|
3gguA |
Hiv pr drug resistant patient's variant in complex with darunavir |
|
88
|
337
|
3gw5A |
Crystal structure of human renin complexed with a novel inhibitor |
|
100
|
339
|
3fv3A |
Secreted aspartic protease 1 from candida parapsilosis in complex with pepstatin a |
|
40
|
203
|
3fsmA |
Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [l-ala51,d-ala51'] hiv-1 protease molecule |
|
89
|
337
|
3g72A |
Design and preparation of potent, non-peptidic, bioavailable renin inhibitors |
|
81
|
325
|
3fnsA |
Crystal structure of histo-aspartic protease (hap) from plasmodium falciparum |
|
89
|
338
|
3g70A |
Design and preparation of potent, non-peptidic, bioavailable renin inhibitors |
|
86
|
341
|
3g6zA |
Design and preparation of potent, non-peptidic, bioavailable renin inhibitors |
|
16
|
99
|
3fx5A |
Structure of hiv-1 protease in complex with potent inhibitor kni-272 determined by high resolution x-ray crystallography |
|
79
|
326
|
3fnuA |
Crystal structure of kni-10006 bound histo-aspartic protease (hap) from plasmodium falciparum |
|
27
|
111
|
3fivA |
Crystal structure of feline immunodeficiency virus protease complexed with a substrate |
|
84
|
329
|
3f9qA |
Re-refinement of uncomplexed plasmepsin ii from plasmodium falciparum. |
|
95
|
387
|
3fktA |
Crystal structure of human beta secretase complexed with spiropiperdine iminohydantoin inhibitor |
|
65
|
323
|
3fntA |
Crystal structure of pepstatin a bound histo-aspartic protease (hap) from plasmodium falciparum |
|
17
|
99
|
3ekyA |
Crystal structure of wild-type hiv protease in complex with the inhibitor, atazanavir |
|
18
|
99
|
3ekvA |
Crystal structure of the wild type hiv-1 protease with the inhibitor, amprenavir |
|
78
|
330
|
3er5E |
The active site of aspartic proteinases |
|
17
|
99
|
3ektA |
Crystal structure of the inhibitor darunavir (drv) in complex with a multi-drug resistant hiv-1 protease variant (l10f/g48v/i54v/v64i/v82a) (refer: flap+ in citation.) |
|
78
|
330
|
3er3E |
The active site of aspartic proteinases |
|
96
|
389
|
3exoA |
Crystal structure of bace1 bound to inhibitor |
|
17
|
99
|
3el0A |
Crystal structure of the inhibitor nelfinavir (nfv) in complex with a multi-drug resistant hiv-1 protease variant (l10i/g48v/i54v/v64i/v82a) (refer: flap+ in citation) |
|
17
|
99
|
3ekwA |
Crystal structure of the inhibitor atazanavir (atv) in complex with a multi-drug resistance hiv-1 protease variant (l10i/g48v/i54v/v64i/v82a) refer: flap+ in citation. |
|
16
|
99
|
3ecgA |
High resolution hiv-2 protease structure in complex with antiviral inhibitor grl-98065 |
